Highly specific role of hypocretin (Orexin) neurons: Differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level

Journal of Neuroscience

Volumn 31, Issue 43, 2011, Pages 15455-15467

  McGregor, Ronald ^a,b   Wu, Ming Fung ^a,b   Barber, Grace ^a,b   Ramanathan, Lalini ^a,b   Siegel, Jerome M ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OREXIN; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; AVOIDANCE BEHAVIOR; CIRCADIAN RHYTHM; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; INSTRUMENTAL CONDITIONING; LIGHT DARK CYCLE; MALE; MOUSE; NERVE CELL; NONHUMAN; PHOTOSTIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINFORCEMENT; REWARD; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BRAIN; CIRCADIAN RHYTHM; CONDITIONING, OPERANT; DRINKING; EATING; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ELECTROSHOCK; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGHT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NEUROPEPTIDES; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SPECTRUM ANALYSIS;

EID: 80054885816     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4017-11.2011     Document Type: Article

References (62)

1. Adametz JH (1959) Rate of recovery of functioning in cats with rostral reticular lesions; an experimental study. J Neurosurg 16:85-97.
2. Basheer R, Sherin JE, Saper CB, Morgan JI, McCarley RW, Shiromani PJ (1997) Effects of sleep on wake-induced c-fos expression. J Neurosci 17:9746-9750.
3. Blanco-Centurion C, Gerashchenko D, Shiromani PJ (2007) Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci 27:14041-14048.
4. Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A (2009) Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29:11215-11225.
5. Boutrel B, de Lecea L (2008) Addiction and arousal: the hypocretin connection. Physiol Behav 93:947-951.
6. Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F (2007) Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13:150-155.
7. Brundin L, Björkqvist M, Träskman-Bendz L, Petersén A (2009) Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. J Affect Disord 113:179-182.
8. Canteras NS, Ribeiro-Barbosa ER, Goto M, Cipolla-Neto J, Swanson LW (2011) The retinohypothalamic tract: comparison of axonal projection patterns from four major targets. Brain Res Rev 65:150-183.
9. Celesia GG, Jasper HH (1966) Acetylcholine released from cerebral cortex in relation to state of activation. Neurology 16:1053-1063.
10. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-451.
11. Dahlström A, Fuxe K (1964) Localization of monoamines in the lower brain stem. Experientia 20:398-399.
12. Deadwyler SA, Porrino L, Siegel JM, Hampson RE (2007) Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci 27:14239-14247.
13. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95:322-327.
14. Espanã RA, Baldo BA, Kelley AE, Berridge CW (2001) Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106:699-715.
15. Espanã RA, Reis KM, Valentino RJ, Berridge CW (2005) Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J Comp Neurol 481:160-178.
16. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE (2001) Fos expression in orexin neurons varies with behavioral state. J Neurosci 21:1656-1662.
17. Funato H, Tsai AL, Willie JT, Kisanuki Y, Williams SC, Sakurai T, Yanagisawa M (2009) Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab 9:64-76.
18. Furlong TM, Vianna DM, Liu L, Carrive P (2009) Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur J Neurosci 30:1603-1614.
19. Franklin K, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic.
20. Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, Kilduff TS, Lappi DA, Shiromani PJ (2001) Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 21:7273-7283.
21. Goel N, Banks S, Mignot E, Dinges DF (2010) DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue. Neurology 75:1509-1519.
22. Grasing K, Li N, He S, Parrish C, Delich J, Glowa J (2003) A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats. Psychopharmacology (Berl) 168:387-396.
23. Guilleminault C, Anognos A (2000) Narcolepsy. In: Principles and practice of sleep medicine (Kryger MH, Roth T, Dement WC, eds), pp 676-686. Philadelphia: W.B. Saunders.
24. Hajek M, Meier-Ewert K, Wirz-Justice A, Tobler I, Arendt J, Dick H, Fink G (1989) Bright white light does not improve narcoleptic symptoms. Eur Arch Psychiatry Neurol Sci 238:203-207.
25. Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437:556-559.
26. Henriques JB, Davidson RJ (2000) Decreased responsiveness to reward in depression. Cogn Emot 14:711-724.
27. Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, Komuro I, Fukuda Y, Kuwaki T (2003) Attenuated defense response and low basal blood pressure in orexin knockout mice.AmJ Physiol Regul Integr Comp Physiol 285:R581-R593.
28. Kiss A (2007) Immobilization induced fos expression in the medial and lateral hypothalamic areas: a limited response of hypocretin neurons. Ideggyogy Sz 60:192-195.
29. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE (2003) Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23:7-11.
30. Lai YY, Siegel JM (1991) Pontomedullary glutamate receptors mediating locomotion and muscle tone suppression. J Neurosci 11:2931-2937.
31. Lee MG, Hassani OK, Jones BE (2005) Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 25:6716-6720.
32. Lesauter J, Silver R, Cloues R, Witkovsky P (2011) Light exposure induces short- and long-term changes in the excitability of retinorecipient neurons in suprachiasmatic nucleus. J Neurophysiol 106:576-588.
33. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The REM sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor gene. Cell 98:365-376.
34. Luppi PH, Gervasoni D, Verret L, Goutagny R, Peyron C, Salvert D, Leger L, Fort P (2006) Paradoxical (REM) sleep genesis: the switch from an aminergic-cholinergic to a GABAergic-glutamatergic hypothesis. J Physiol Paris 100:271-283.
35. Lutter M, Krishnan V, Russo SJ, Jung S, McClung CA, Nestler EJ (2008) Orexin signaling mediates the antidepressant-like effect of calorie restriction. J Neurosci 28:3071-3075.
36. McGregor R, Wu M-F, Boehmer LN, Abordo K, Siegel JM (2007) Reduced motivated behavior in hypocretin knockout mice. Soc Neurosci Abstr 33:97.7.
37. Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M (2004) Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 101:4649-4654.
38. Mileykovskiy BY, Kiyashchenko LI, Siegel JM (2005) Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46:787-798.
39. Mishima K, Fujiki N, Yoshida Y, Sakurai T, Honda M, Mignot E, Nishino S (2008) Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy. Sleep 31:1119-1126.
40. Moorman DE, Aston-Jones G (2009) Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats. Alcohol 43:379-386.
41. Moruzzi G, Magoun HW (1949) Brain stem reticular formation and activation of the EEG. Electroencephalogr Clin Neurophysiol 1:455-473.
42. Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M, Sakurai T (2000) Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res 873:181-187.
43. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015.
44. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991-997.
45. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, et al (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585.
46. Sakurai T, Nagata R, Yamanaka A, Kawamura H, Tsujino N, Muraki Y, Kageyama H, Kunita S, Takahashi S, Goto K, Koyama Y, Shioda S, Yanagisawa M (2005) Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 46:297-308.
47. Scammell TE, Willie JT, Guilleminault C, Siegel JM (2009) A consensus definition of cataplexy in mouse models of narcolepsy. Sleep 32:111-116.
48. Schwarz PB, Yee N, Mir S, Peever JH (2008) Noradrenaline triggers muscle tone by amplifying glutamate-driven excitation of somatic motoneurones in anaesthetized rats. J Physiol 586:5787-5802.
49. Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ (2010) Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol Psychiatry 67:753-760.
50. Siegel JM (2004) Hypocretin (orexin): role in normal behavior and neuropathology. Annual Rev Psychol 55:125-148.
51. Sinton CM (2011) Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 15:197-207.
52. Szklo-Coxe M, Young T, Finn L, Mignot E (2007) Depression: relationships to sleep paralysis and other sleep disturbances in a community sample. J Sleep Res 16:297-312.
53. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-474.
54. Thannickal TC, Lai YY, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130:1586-1595.
55. Thannickal TC, Lai YY, Siegel JM (2008) Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease. Brain 131:e87.
56. Thannickal TC, Nienhuis R, Siegel JM (2009) Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 32:993-998.
57. Turner SG, Sechzer JA, Liebelt RA (1967) Sensitivity to electric shock after ventromedial hypothalamic lesions. Exp Neurol 19:236-244.
58. Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, de Lecea L (2004) Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24:11439-11448.
59. Wu MF, John J, Maidment N, Lam HA, Siegel JM (2002) Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 283:R1079-R1086.
60. Wu MF, Nienhuis R, Maidment N, Lam HA, Siegel JM (2011) Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy. J Neurosci 31:6305-6310.
61. Zhang S, Lin L, Kaur S, Thankachan S, Blanco-Centurion C, Yanagisawa M, Mignot E, Shiromani PJ (2007) The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience 148:34-43.
62. Zhu L, Onaka T, Sakurai T, Yada T (2002) Activation of orexin neurons after noxious but not conditioned fear stimuli in rats. Neuroreport 13: 1351-1353.